An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.

Saved in:
Bibliographic Details
Title: An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.
Authors: Iniguez, Eva1, Schocker, Nathaniel S.2, Subramaniam, Krishanthi3, Portillo, Susana1, Montoya, Alba L.2, Al-Salem, Waleed S.3, Torres, Caresse L.1, Rodriguez, Felipe1, Moreira, Otacilio C.4, Acosta-Serrano, Alvaro3,5, Michael, Katja2, Almeida, Igor C.1 icalmeida@utep.edu, Maldonado, Rosa A.1 ramaldonado@utep.edu
Source: PLoS Neglected Tropical Diseases. 10/25/2017, Vol. 11 Issue 10, p1-25. 25p.
Database: Academic Search Ultimate
Description
ISSN:19352727
DOI:10.1371/journal.pntd.0006039